GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice

Psychopharmacology

Volumn 177, Issue 1-2, 2004, Pages 130-140

  Maldonado, Concepción ^a   Rodríguez Arias, Marta ^a   Aguilar, María A ^a   Miñarro, José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Conditioned place aversion; GHB; Mice; Morphine; Naloxone; Withdrawal syndrome

Indexed keywords

4 HYDROXYBUTYRIC ACID; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APPARATUS; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DRUG WITHDRAWAL; JUMPING; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREMOR; VALIDATION PROCESS;

ANIMALS; AVOIDANCE LEARNING; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MORPHINE; NALOXONE; SODIUM OXYBATE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 12144259738     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1927-2     Document Type: Article

References (44)

1. Azar MR, Jones BC, Schulteis G (2003) Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology 170:42-50
2. Beardsley PM, Balster RL, Harris LS (1996) Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Psychopharmacology 127:315-322
3. b receptor agonist baclofen. Life Sci 70:395-401
4. Brain PF, McAllister KH, Wamsley SV (1989) Drug effects on social behaviours. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Methods in ethopharmacology. Neuromethods series, vol 13. Humana Press, Clifton, pp 687-739
5. Broseta I, Rodríguez-Arias M, Stinus L, Miñarro J (2001) Ethological analysis of morphine withdrawal with different dependence programs in male mice. Prog Neuropsychopharmacol Biol Psychiatry 26:335-347
6. Broughton R, Mamelak M (1979) The treatment of narcolepsy-catalepsy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci 6:1-6
7. Cheramy A, Nieoullon A, Glowinski J (1977) Stimulating effects of γ-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat. J Pharmacol Exp Ther 202:283-293
8. Chin MY, Kreutzer RA, Byer JE (1992) Acute poisoning from gammahydroxybutyrate in California. West J Med 156:380-384
9. Craig K, Gomez HG, McManus JL, Bania TC (2000) Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J Emerg Med 18:65-70
10. Diana M, Mereu G, Mura A, Fadda F, Passino N, Gessa GL (1991) Low doses of γ-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res 566:208-211
11. Diana M, Pistis M, Muntoni A, Gessa G (1996) Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence. Neuroscience 71:411-415
12. Diaz SL, Kemmling AK, Balerio GN (2003) Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal. Neurochem Int 42:293-298
13. Dyer JE (1991) Gamma hydroxybutyrate: a health-food product producing coma and seizure like activity. Am J Emerg Med 9:321-324
14. Fattore L, Martellotta MC, Cossu G, Fratta W (2000) Gamma-hydroxybutyric acid an evaluation of its rewarding properties in rats and mice. Alcohol 20:247-256
15. Feigenbaum JJ, Howard SG (1997) Naloxone reverses the inhibitory effect of γ-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis study. Neurosci Lett 224:71-74
16. Feigenbaum JJ, Simantov R (1996) Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding. Neurosci Lett 212:5-8
17. Fernandez-Espejo E, Cador M, Stinus L (1995) Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score.". Psychopharmacology 122:122-130
18. Frederick SL, Galloway GP, Staggers F, Stalcup SA, Smith D (1994) Gamma-hydroxybutyrate: a putative neurotransmitter that is abused and causes physical dependence. In: Harris LS (ed) Problems of drug dependence, 1994. National Institute on Drug Abuse Research Monograph Series 153. National Institute on Drug Abuse, Rockville, p 101
19. Friedman J, Westlake R, Furman M (1996) "Grievous bodily harm": gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome. Neurology 46:469-471
20. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Gerrara SD, Fadda F, Gessa GL (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2:787-789
21. Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL (1992) Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol Clin Exp Res 16:673-676
22. Gallimberti L, Cibin M, Pagnin P, Sabbion R, Pani PP, Pirastu R, Ferrara SD, Gessa GL (1993) Gamma-hydroxybutyric acid for treatment of opioid withdrawal syndrome. Neuropsychopharmacology 9:77-81
23. Gallimberti L, Schifano F, Forza G, Miconi L, Ferrara SD (1994) Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal. Eur Arch Psychiatr Clin Neurosci 244:113-114
24. Gallimberti L, Spella MR, Soncini CA, Gessa GL (2000) Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 20:257-262
25. Galloway GP, Frederick SL; Staggers FE, Gonzales M, Stalcup SA, Smith DE (1997) Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 92:89-96
26. Gellert VF, Holtzman SG (1978) Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 205:536-546
27. Gobaille S, Schmidt C, Cupo A, Herbrecht F, Maitre M (1994) Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels. Neuroscience 60:637-648
28. Hechler V, Gobaille S, Bourguignon J, Maitre M (1991) Extracellular events induced by γ-hydroxybutyrate in striatum: a microdialysis study. J Neurochem 56:938-944
29. Higgins GA, Sellers EM (1994) Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol Biochem Behav 48:1-8
30. Howard SG, Feigenbaum JJ (1997) Effect of gamma-hydroxybutyrate on central dopamine release in vivo. Biochem Pharmacol 53:103-110
31. Itzhak Y, Ali SF (2002) Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann N Y Acad Sci 965:451-460
32. Laborit G, Larcan A, Kind A (1962) Le gamma-hydroxybutyrate en anesthesie neuro-chirurgicale. Neurochirurgie 8:104-107
33. Maitre M (1997) The γ-hydroxybutytate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361
34. Maldonado R, Stinus L, Gold LH, Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677
35. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Miñarro J (2001a) Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res 121:189-197
36. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Miñarro J (2001b) Effects of CGS 10746B on hyperactivity and place preference induced by morphine. Behav Brain Res 126:23-32
37. Martellota MC, Fattore L, Cossu G, Fratta W (1997) Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm. Psychopharmacology 132:1-5
38. Mucha RF (1987) Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in rats. Brain Res 418:214-220
39. Popik P, Danysz W (1997) Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. J Pharmacol Exp Ther 280:854-865
40. Schmidt-Mutter C, Gobaille S, Muller C, Maitre M (1999) Prodynorphin and proenkephalin mRNAs are increased in rat brain alters acute and chronic administration of gamma-hydroxybutyrate. Neurosci Lett 262:65-68
41. Stephens BG, Baselt RC (1994) Driving under the influence of GHB? J Anal Toxicol 18:357-358
42. Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773
43. Vayer P, Mandel P, Maitre M (1987) Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 41:1547-1557
44. Whiter JC (1981) The stimulus properties of γ-hydroxybutyrate. Psychopharmacology 73:372-375